The EHA Research Roadmap: Platelet Disorders

The EHA Research Roadmap: Platelet Disorders

Bibliographic Details
Main Authors:	Carlo Balduini, Kathleen Freson, Andreas Greinacher, Paolo Gresele, Thomas Kühne, Marie Scully, Tamam Bakchoul, Paul Coppo, Tadeja Dovc Drnovsek, Bertrand Godeau, Yves Gruel, A. Koneti Rao, Johanna A. Kremer Hovinga, Michael Makris, Axel Matzdorff, Andrew Mumford, Alessandro Pecci, Hana Raslova, José Rivera, Irene Roberts, Rüdiger E. Scharf, John W. Semple, Christel Van Geet
Format:	Article
Language:	English
Published:	Wolters Kluwer 2021-07-01
Series:	HemaSphere
Online Access:	http://journals.lww.com/10.1097/HS9.0000000000000601

Similar Items

The EHA Research Roadmap: Anemias
by: Achille Iolascon, et al.
Published: (2021-07-01)

The EBMT/EHA CAR-T Cell Handbook
Published: (2022)

The EBMT/EHA CAR-T Cell Handbook
Published: (2022)

Fundamentals for a Systematic Approach to Mild and Moderate Inherited Bleeding Disorders: An EHA Consensus Report
by: Francesco Rodeghiero, et al.
Published: (2019-10-01)

Serological and functional tests for the diagnosis of heparin-induced thrombocytopenia
by: Elvira Maličev, et al.
Published: (2012-02-01)

EHA Research Roadmap on Hemoglobinopathies and Thalassemia: An Update
by: Achille Iolascon, et al.
Published: (2019-06-01)

Telemedicine networks of EHAS Foundation in Latin America
by: Ignacio ePrieto-Egido, et al.
Published: (2014-10-01)

Correction Notice: The EHA Research Roadmap: Anemias
Published: (2021-10-01)

The EHA Research Roadmap: Malignant Myeloid Diseases
by: Hartmut Döhner, et al.
Published: (2021-09-01)

EHA2021 Virtual Congress Abstract Book
Published: (2021-06-01)

Fair Pricing of Innovative Medicines: An EHA Position Paper
by: Anton Hagenbeek, et al.
Published: (2020-10-01)

The EHA Research Roadmap: Blood Coagulation and Hemostatic Disorders
by: Sabine Eichinger, et al.
Published: (2021-10-01)

HEPARIN INDUCED THROMBOCYTOPENIA
by: Matija Kozak, et al.
Published: (2008-03-01)

Double Hit Lymphoma Diagnosis and Treatment in Europe—A Cross-Sectional Survey of Clinical Practice by the EHA Lymphoma Working Party (EHA LyG)
by: Igor Aurer, et al.
Published: (2020-12-01)

Access to Affordable Orphan Medicines in Europe: An EHA Position Paper
by: Giampaolo Merlini, et al.
Published: (2020-10-01)

Personalized Treatment for Hematologic Diseases in Europe: An EHA Position Paper
by: Ulrich Jäger, et al.
Published: (2020-10-01)

EHA Guidance Document The process of CAR-T cell therapy in Europe
Published: (2019-08-01)

The EHA Research Roadmap: Immune-based Therapies for Hematological Malignancies
by: Hermann Einsele, et al.
Published: (2021-10-01)

EHA Endorsement of the European Guidelines for Myelodysplastic Syndromes, MDS-RIGHT
by: Sabine Blum, et al.
Published: (2021-09-01)

DETERMINATION OF FETAL BLOOD GROUP IN PREGNANCY
by: Irena Bricl, et al.
Published: (2004-12-01)

Prevention and diagnostics of haemolytic disease of the fetus and newborn
by: Klara Železnik, et al.
Published: (2012-12-01)

Obravnava nosečnic glede na tip RhD
by: Janja Jerina, et al.
Published: (2020-01-01)

EHA Scientific Working Groups: Connecting Science and Spreading Knowledge in Hematology
by: Pieter Sonneveld
Published: (2020-04-01)

EHA Endorsement of ESMO Clinical Practice Guidelines for Marginal Zone Lymphomas
by: Marco Ladetto, et al.
Published: (2020-04-01)

The EHA2021 Annual Congress Award Winners: Celebrating Excellence in Hematology
by: John Gribben, et al.
Published: (2021-06-01)

Semibatch ST/2-EHA Emulsion polymerization : The Effect of Surfactants and Monomer polarity
by: Jian-Shou Chen, et al.
Published: (2011)

Semibatch STY/2-EHA Emulsion Polymerization：The Effect of Non-ionic Surfactants
by: Yu-hsiang Lin, et al.
Published: (2010)

Multiple Myeloma: EHA-ESMO Clinical Practice Guidelines for Diagnosis, Treatment and Follow-up
by: Meletios A. Dimopoulos, et al.
Published: (2021-02-01)

Immune-based Therapies for Hematological Malignancies: An Update by the EHA SWG on Immunotherapy of Hematological Malignancies
by: Hermann Einsele, et al.
Published: (2020-08-01)

EU-Wide Access to High-quality, Affordable Precision Diagnostics: An EHA Position Paper
by: Elizabeth Macintyre, et al.
Published: (2020-06-01)

EHA Endorsement of ESMO Clinical Practice Guidelines for Newly Diagnosed and Relapsed Follicular Lymphoma
by: Marco Ladetto, et al.
Published: (2021-05-01)

EHA Endorsement of ESMO Clinical Practice Guidelines for Newly Diagnosed and Relapsed Mantle Cell Lymphoma
by: Kim Linton, et al.
Published: (2020-10-01)

UPKBEHA H UPKBEHOCAOBEHCKA AEKCHKA Y HAPOAHHM TOBOPHMA H EbEHA AAAnTAIJHJA
by: Gordana Jovanović
Published: (1989-01-01)

Characterization of EhaJ, a new autotransporter protein from enterohemorrhagic and enteropathogenic Escherichia coli
by: Donna M Easton, et al.
Published: (2011-06-01)

EHA Endorsement of ESMO Clinical Practice Guidelines for Diagnosis, Treatment, and Follow-up for Waldenström’s Macroglobulinemia
by: Philipp B. Staber, et al.
Published: (2021-10-01)

Primary Immune Thrombocytopenia: Novel Insights into Pathophysiology and Disease Management
by: Anurag Singh, et al.
Published: (2021-02-01)

EHA Endorsement of ESMO Clinical Practice Guidelines for Diagnosis, Treatment, and Follow-up of Chronic Lymphocytic Leukemia
by: Barbara Eichhorst, et al.
Published: (2021-01-01)

Affordability of Medicines a Top Priority for EHA: Toward a Fair Pricing Model for Innovative Medicines
by: Anton Hagenbeek, et al.
Published: (2017-12-01)

Correction Notice: Multiple Myeloma: EHA-ESMO Clinical Practice Guidelines for Diagnosis, Treatment and Follow-up
Published: (2021-04-01)

Outside-in signalling generated by a constitutively activated integrin αIIbβ3 impairs proplatelet formation in human megakaryocytes.
by: Loredana Bury, et al.
Published: (2012-01-01)